About NCCU Academics Admissions Athletics Campus Life Giving Research

Hernan A Navarro

Profile Image

Contact Information

Title:
Director
Email:
hnavarro@nccu.edu
Phone:
(919) 530-7001
Fax:
(919) 530-6600
Office:
1011 Biomanufacturing Research Institute and Technology Enterprise (BRITE)

Biography

North Carolina Central University (NCCU) has named Hernan Navarro, Ph.D., as director of the Biomedical Research Institute and Technology Enterprise (BRITE).

Having begun his new role on July 9, 2018, Dr. Navarro comes to NCCU from RTI International, where he had been chief scientist at the Center for Drug Discovery in Research Triangle Park from Oct. 2016 until Nov. 2017, when he retired. From 2012 to 2016, he was vice president for Discovery Sciences at RTI. He started working for the company in 1990 as a research pharmacologist.
A native of Washington, D.C., Dr. Navarro earned a Bachelor of Science degree in botany from Duke University in 1981 and a doctorate in anatomy from the University of Kentucky, Lexington, in 1987.
He earned a National Research Service Award to conduct postdoctoral research in the Department of Pharmacology at Duke University Medical Center from 1986 to 1990, where he examined the effects of prenatal drug exposure on infants? central and peripheral nervous systems.

Dr. Navarro has published more than 100 works of research and holds a number of patents. He was an adjunct professor in integrated toxicology at Duke University from 2003 to 2012 and served as an adjunct for the University of North Carolina Department of Medicine from 2014 to 2018.

At BRITE, Dr. Navarro?s role will include overall leadership and supervision of the research institute and its two dozen faculty members as they conduct drug-discovery and biomanufacturing research related to diseases such as diabetes, cancer, neurodegenerative diseases and other metabolic disorders. BRITE owns a 475,000 chemical compound library ? the largest academic collection in the United States.
Dr. Navarro will work collaboratively with the director of NCCU?s Julius L. Chambers Biomedical/Biotechnology Research Institute (BBRI) and deans of academic units to foster sustainable research collaborations, and further increase national awareness of research conducted at NCCU.
 
NCCU complies with Title IX of the Education Amendments of 1972, which prohibits discrimination on the basis of sex in all programs and activities (including sexual harassment and sexual violence) in the University's educational programs and activities. For additional resources or to file a Title IX complaint, visit the NCCU's Title IX webpage.
© 2019 North Carolina Central University 1801 Fayetteville St., Durham, NC 27707